#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Central nervous system neoplasm Hereditary optic atrophy Granulomatosis with polyangiitis Alagille syndrome Precursor T-lymphoblastic lymphoma/leukaemia recurrent Anti-HLA antibody test positive Mucopolysaccharidosis I Pulmonary fibrosis Inclusion body myositis Frostbite Ovarian cancer stage IV Autologous haematopoietic stem cell transplant IgA nephropathy Hereditary spastic paraplegia Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Treatment Paroxysmal nocturnal haemoglobinuria – Treatment Lysosomal storage disorder – Life with Disease Pleomorphic leiomyosarcoma – Diagnostics Synovial sarcoma metastatic – Basic Information Cystic fibrosis lung – Diagnostics Krabbe’s disease – Diagnostics Mucopolysaccharidosis II – Trials in Disease Sarcoma – Life with Disease Fabry’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-1084 Salmeterol Oxybuprocaine Hydrochloride Pantothenate Sodium AZD6234 Bi 3720931 Empasiprubart 177Lu-Rhpsma-10.1 Pervi-Neo Jab-21822 Eribulin Alogliptin Arginine Hydrochloride Citalopram Ibuprofen Sodium Dihydrate Caffeine [18F]CPFPX Metamizole Sodium Monohydrate Emapalumab ANUMIGILIMAB More therapies…

    Learn about Your Condition

    Anal fistula Arthroscopy Alcohol abuse Dysmenorrhoea Brain neoplasm Bile duct adenocarcinoma Essential hypertension Prodromal Alzheimer's disease Colitis ulcerative Skin cancer Status epilepticus Cold type haemolytic anaemia Lupus nephritis Hypersensitivity Macular degeneration More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Guselkumab
    Austria Belgium France Italy The Netherlands Norway +3

  • Study on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Fluorouracil
    France

  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial flutter
    • Chronic coronary syndrome
    • Acute coronary syndrome
    Investigated Drugs:
    • Prasugrel
    • Clopidogrel
    • Acetylsalicylic Acid
    Belgium France Germany Italy The Netherlands Poland +1

  • Comparison of General Anesthesia versus High-Flow Nasal Cannula Sedation in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Rocuronium Bromide
    • Propofol
    • Fentanyl Citrate
    Spain

  • Study on Preventing Cytomegalovirus Infection Using Valganciclovir in Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Valganciclovir
    France

  • Study on M2RLAB Cell Therapy for Treating Acute Kidney Injury in Patients After Heart Surgery

    Recruiting

    2 1
    Investigated Drugs:
    • M2Rlab
    Spain
Previous Page
1 … 340 341 342 343 344 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!